Envisioning a world without blindness: New treatments for AMD

by Mark Steedman, PhD

Eye

This week’s blog is the second in a series focusing on eye health, which we are writing in advance of the launch of a global report on eye health at the November 2018 World Innovation Summit for Health (WISH). Our first blog in the series focused on glaucoma. This blog examines in more detail another leading cause of eye morbidity that affects millions of people around the world – age-related macular degeneration (AMD).

Continue reading

Posted on 10/08/2018 | 0 Comments

In the spotlight: How might the appointment of our new Health Secretary impact health and care?

by Karen Taylor, Director, Centre for Health Solutions

Lights

In the three weeks since the NHS celebrated its 70th birthday, much has happened. From the appointment of a new Health Secretary, Matt Hancock MP, to the unravelling of the details of the national pay award. Meanwhile, hospital activity shows no let up and concerns over staffing and other resource shortages continue to build. This week’s blog provides my take on the Health Secretary’s maiden speech and its implications for the current health care system.

Continue reading

Posted on 03/08/2018 | 0 Comments

Blockchain: Picking the right links for the Life Science and Health Care industries

by Amen Sanghera, Analyst, UK Deloitte Centre for Health Solutions and Rui Zhou, Consultant, Deloitte Canada

Chain

Blockchain is increasingly touted as the technology that could transform many of the challenges facing healthcare and life sciences; whether it is providing secure and interoperable electronic health records (EHR), increasing the integrity of clinical trials data or improving the transparency of life science’s supply chain operations. While, the technology itself is not revolutionary, using it in the right situation, especially where trust, consensus or immutability are essential to the operations of the Life Science and Health care industries, could be transformational.

Continue reading

Posted on 27/07/2018 | 0 Comments

R&D leaders roundtable: the key takeaways to help address pharma’s R&D productivity challenge

by Colin Terry, Partner, Deloitte Consulting

Future-of-rd

Following the launch of our eighth annual report ‘A new future for R&D? Measuring the return from pharmaceutical innovation 2017’, we hosted a peer-to-peer discussion on how R&D leaders can address R&D performance trends. The roundtable stimulated many insightful discussions among the senior R&D executives in attendance, and below are some of the key takeaways that resonated most with me.

Continue reading

Posted on 27/07/2018 | 0 Comments

Medtech and the Internet of Medical Things: How connected medical devices are transforming health care

by Dr. Mark Steedman, Research Manager, Centre for Health Solutions

Medtech

This week, we launched our report Medtech and the Internet of Medical Things: How connected medical devices are transforming health care. Our report takes an in-depth look at how connectivity is impacting the medtech industry, the challenges and opportunities that medtech companies are facing due to the rise of the Internet of Medical Things (IoMT), the specific role connected medical devices are playing in the growth of the IoMT and what the future will bring for medtech and the IoMT.

Continue reading

Posted on 13/07/2018 | 0 Comments

The NHS at 70 – time to celebrate our own independence day

by Karen Taylor, Director, Centre for Health Solutions

Cake

As almost everyone knows, the Fourth of July is American Independence day. My premise for this blog is that the 5th July 1948, which marked the birth of the NHS, was in fact the day that people across the UK were liberated from worry and distress over their own health care. Consequently, a fitting tribute to the NHS on its 70th birthday would be to declare 5 July as our own ‘independence day’, and fight with all our might to retain the principles and values of the NHS.

Continue reading

Posted on 06/07/2018 | 0 Comments

Five barriers that could keep biosimilar manufacturers from cracking the US market

by James Forsyth, Director, Deloitte MCS Limited, and Cameron McClearn, Principal, Deloitte Consulting LLP

Writing

This week’s blog by James Forsyth (Director Deloitte MCS) and Cameron Mclearn (Principle Deloitte Consulting US) featured on the US Center for Health Solutions blog, A view from the Center, earlier this week.1 The article explores the challenges that are keeping biosimilar manufacturers from gaining more traction in the US market.

Continue reading

Posted on 29/06/2018 | 0 Comments

Caring for Carers: Why everyone has a role to play

by Karen Taylor, Director, Centre for Health Solutions

Deloitte-uk-hand-seedling

Last week was National Carers week, the annual awareness campaign aimed at recognising the seven million people across the UK who provide unpaid care for a family member or friend.1 It highlights the enormous challenges that carers face and the vital contribution they make to families and communities throughout the UK. Therefore I thought it timely to reflect on the contribution made to society by the millions of unpaid carers and consider what can be done to support those who provide the much needed, immensely valuable, unpaid care to their family and friends.

Continue reading

Posted on 22/06/2018 | 0 Comments

The importance of early diagnosis in cancer

by Amen Sanghera

Scan

Recently I read that cancer was discovered in a 1.7 million year old ancient human fossil.1 This discovery sparked my interest to understand some of the more recent developments in cancer research and the importance of early diagnosis in successfully treating cancers. Since the 1970s the survival rates for cancer have doubled, with 50 per cent of people diagnosed with cancer now surviving their disease for ten years or more.2

Continue reading

Posted on 15/06/2018 | 0 Comments

Virtual health: Considering the technology implications

by Tim Smith, Principal, Deloitte Consulting LLP

X-ray

This week’s blog by Tim Smith, Deloitte’s national leader for Healthcare Information Technology (HIT) in the US, featured on the US Center for Health Solutions blog, A view from the Center, in March 2018.1 Following the HIMSS18 conference in the March 2018, Tim used the blog to explore the importance, challenges and considerations of virtual care programmes for organisations looking to implement them.

Continue reading

Posted on 08/06/2018 | 0 Comments

Emerging technologies can boost performance in clinical trials

by Greg Reh, Vice Chairman, US and Global Life Sciences Leader, Deloitte LLP

Athletes

This week’s blog by Greg Reh, Deloitte’s Global Life Sciences Leader first featured on the US Center for Health Solutions blog, A view from the Center.i In it Greg explores how emerging technologies can improve enrolment in, remove barriers of participation and increase drug adherence in pharma clinical trials.

Continue reading

Posted on 01/06/2018 | 0 Comments